{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:03:04Z","timestamp":1784181784433,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijtb.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:57:51Z","timestamp":1754413071000},"page":"364-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Limited success and high attrition in the 9-month all-oral regimen for MDR-TB: Evidence from a tertiary care setting in Indonesia"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-5619","authenticated-orcid":false,"family":"Soedarsono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariani","family":"Permatasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catur","family":"Agustiyanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky Reinold Christofel","family":"Rampengan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2025.08.001_bib1","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.ijtb.2025.08.001_bib2","series-title":"WHO Consolidated Guidelines on Tuberculosis. Module 4 Therapy Drug Resistant Tuberculosis Therapy, 2022 Update","year":"2022"},{"key":"10.1016\/j.ijtb.2025.08.001_bib3","unstructured":"Van Deun A, Maug AK, Hamid Salim MA, et al. Short, Highly Effective, and Inexpensive Standardized Therapy of Multidrug-Resistant Tuberculosis. Am J."},{"key":"10.1016\/j.ijtb.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","volume":"182","year":"2010","journal-title":"Respir Crit Care Med"},{"issue":"10150","key":"10.1016\/j.ijtb.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Therapy correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijtb.2025.08.001_bib6","first-page":"267","article-title":"Ototoxicity associated with the therapy of multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"6","author":"Cox","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijtb.2025.08.001_bib7","series-title":"Rapid Communication: Key Changes to the Therapy of Drug-Resistant Tuberculosis","year":"2019"},{"key":"10.1016\/j.ijtb.2025.08.001_bib8","series-title":"Technical Guidelines for Managing Drug-Resistant Tuberculosis in Indonesia","year":"2020"},{"key":"10.1016\/j.ijtb.2025.08.001_bib9","series-title":"Strategi Nasional Pengendalian Tuberkulosis 2020\u20132024 [National Tuberculosis Control Strategy 2020\u20132024] [Indonesian]","year":"2023"},{"key":"10.1016\/j.ijtb.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijid.2020.01.042","article-title":"MDR\/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network","volume":"92","author":"Migliori","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijtb.2025.08.001_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the therapy of drug-resistant tuberculosis, 2020 update","volume":"57","author":"Mirzayev","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2025.08.001_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1408316","article-title":"Tracking multidrug-resistant tuberculosis: a 30-year analysis of global, regional, and national trends","volume":"12","author":"Song","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijtb.2025.08.001_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12890-021-01735-9","article-title":"Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects","volume":"21","author":"Soedarsono","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.ijtb.2025.08.001_bib14","first-page":"123","article-title":"New all-oral short-term regimen for multidrug-resistant tuberculosis: a semi-randomized controlled trial conducted in China","volume":"24","author":"Zhao","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2025.08.001_bib15","first-page":"1576","article-title":"Factors cause of switching shorter regimen to longer regimen in multidrug-resistant\/rifampicin-resistant tuberculosis treated patients in Dr. Soetomo hospital surabaya, Indonesia","volume":"15","author":"Soedarsono","year":"2021","journal-title":"Indian J For Med Toxicol"},{"issue":"4","key":"10.1016\/j.ijtb.2025.08.001_bib16","first-page":"297","article-title":"Challenges in the implementation of all-oral shorter regimens for drug-resistant TB: a programmatic perspective","volume":"26","author":"Koirala","year":"2022","journal-title":"Int J Tubercul Lung Dis"},{"issue":"11","key":"10.1016\/j.ijtb.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Feasibility, accuracy, and impact of molecular diagnostics for drug-resistant tuberculosis","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ijtb.2025.08.001_bib18","first-page":"406","article-title":"Molecular diagnostics of drug-resistant tuberculosis: advances and challenges","volume":"26","author":"Skripconoka","year":"2020","journal-title":"J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.ijtb.2025.08.001_bib19","article-title":"Advances in rapid diagnostic tests for multi-drug resistant tuberculosis","author":"Rathod","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijtb.2025.08.001_bib20","first-page":"235","article-title":"Bedaquiline and delamanid for drug-resistant tuberculosis: Outcomes from a cohort study","volume":"8","author":"Conradie","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijtb.2025.08.001_bib21","series-title":"Nine-month, all-oral regimens for rifampin-resistant tuberculosis [Preprint]","author":"Guglielmetti","year":"2024"},{"issue":"2","key":"10.1016\/j.ijtb.2025.08.001_bib22","article-title":"Bedaquiline-containing regimens for multidrug-resistant tuberculosis: outcomes in real-world settings","volume":"57","author":"Borisov","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:03:45Z","timestamp":1784178225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570725001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0019570725001775"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.08.001","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited success and high attrition in the 9-month all-oral regimen for MDR-TB: Evidence from a tertiary care setting in Indonesia","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}